scholarly journals Mandala Colouring Therapy And Cognitive Function In Elderly With Dementia

2019 ◽  
Vol 14 (2) ◽  
pp. 127
Author(s):  
Noor Rochmah Ida Ayu TP ◽  
Reni Dwi Setyaningsih ◽  
Wilis Sukmaningtyas
Keyword(s):  
Cognitive Function ◽  
Older Adult ◽  
Research Design ◽  
Mental State ◽  
Aging Process ◽  
Mini Mental State Examination ◽  
Significant Difference ◽  
Before And After ◽  
State Examination ◽  
The Brain

Dementia is a disorder of cognitive function in eldery. It is as one sign of an aging process, where there is a metabolic decline in the brain. Non-pharmacalogical theraphy with art theraphy, Mandala Therapy, believed to improved the cognitive function of older adult with dementia.This study aims to determain the effect of Mandala Therapy to improving cogntive function in elderly. Mandala Colouring Theraphy,which is expected to be able to help  elderly  to increase focus, concentration, reduce anxiety and can be an inherent process of meditation. The research design in this study used quasy experimental with the sample as 37 elderly. The measurement of cognitive function was carried out using the Mini Mental State Examination (MMSE) instrument which was carried out before and after the Mandala color therapy. The results found not significant difference between before and after Mandala colouring therapy (p = 0.324) with a mean decline of 0.69 points, but there were significant differences based on the severity of cognitive function disorders. Coloring therapy needs to be done routinely and continuously in order to provide meaningful results.

scholarly journals Art Therapy on the Cognitive Function of Elderly with Dementia

2020 ◽  
Vol 7 (2) ◽  
pp. 60
Author(s):  
Murdiyanti Prihatin Putri Dewi MPP
Keyword(s):  
Cognitive Function ◽  
Art Therapy ◽  
Mental State ◽  
Aging Process ◽  
Mini Mental State Examination ◽  
The Elderly ◽  
Control Groups ◽  
State Examination

<p><em>The aging process continues as time goes by and there will be an impairment of the organ. Decreased body functions that often appear one of them is a decrease in cognitive function. Most of the elderly experienced dementia by showing changes in behavior. This study was to identify the effect of  art therapy on cognitive function of the elderly with dementia with the design of this study was Quasy Experimental Pre-Post Control Goup Design. There were 82 respondents divided into control groups and intervention groups. Measurement of cognitive function of the elderly with dementia using the Mini-Mental State Examination (MMSE). The result of the research showed that </em><em>there </em><em>wa</em><em>s a significant improvement of </em><em>the </em><em>cognitive function in </em><em>elderly</em><em> with dementi</em><em>a after a</em><em>rt therapy for 4 (four) weeks.</em><em> It can be concluded thatbrain exercise and art therapy exercise can be applied to increase cognitive function towards the elderly.</em></p>

Serum Level of Alkaline Phosphatase Correlates Negatively with Mini-Mental State Examination Score in the Very Elderly of Ashikaga City: Part of the Results of the Ashikaga Longevity Study

2021 ◽  
Author(s):  
Minoru Yamakado
Keyword(s):  
Oxidative Stress ◽  
Alkaline Phosphatase ◽  
Cognitive Function ◽  
Life Expectancy ◽  
Mental State ◽  
Mini Mental State Examination ◽  
Mmse Score ◽  
Healthy Life Expectancy ◽  
Healthy Life ◽  
State Examination

Objective: An important medical issue in both Japan and Ashikaga City is how to extend healthy life expectancy. To determine factors associated with healthy life expectancy, we established a joint study between Ashikaga City and the Ashikaga University Faculty of Nursing called the Ashikaga Longevity Study, using new biomarkers such as Diacron reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) tests as indicators of oxidative stress. In this study, factors related to cognitive function were clarified. Methods: Participants comprised 95 individuals (36 men; mean age, 91.0±5.1 years and 59 women; mean age, 92.2±5.9 years). Cognitive impairment was assessed using the Mini-Mental State Examination (MMSE). Results: MMSE score was ≤23 in 28 subjects (29.5%) and ≥24 in 67 subjects (70.5%). MMSE score showed significant negative correlations with age (p<0.0096), plasma alkaline phosphatase (p=0.0007), and peripheral leukocyte-to-lymphocyte ratio (p=0.0119), and positive correlations with plasma albumin (p=0.0096) and BAP-to-d-ROMs ratio (p=0.0427). Conclusions: These results suggest that cognitive decline may involve brain cell dysfunction due to inflammation based on a reduced ability to control oxidative stress. Not only anti-oxidative aerobic exercise but also anti-oxidative foods, may be necessary to maintain cognitive function.

scholarly journals Sleep Disorders and Cognitive Impairment in Peritoneal Dialysis: A Multicenter Prospective Cohort Study

2019 ◽  
Vol 44 (5) ◽  
pp. 1115-1127 ◽  
Author(s):  
Youlu Zhao ◽  
Yuhui Zhang ◽  
Zhikai Yang ◽  
Jinwei Wang ◽  
Zuying Xiong ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cognitive Impairment ◽  
Peritoneal Dialysis ◽  
Cognitive Function ◽  
Sleep Disorders ◽  
Mental State ◽  
Mini Mental State Examination ◽  
Multicenter Prospective Cohort Study ◽  
State Examination ◽  
Multicenter Prospective Cohort

Background: Patients with chronic kidney disease experience a high burden of sleep disorders, and there are associations between sleep disorders and cognitive impairment. Objectives: Based on our previous cross-sectional survey on cognitive impairment in peritoneal dialysis, we further explored the relationship between sleep disorders and cognitive impairment, and predictors for declining cognitive function. Method: We conducted a multicenter prospective cohort study enrolling 458 clinically stable patients on peritoneal dialysis who were then followed up for 2 years.Demographic data, comorbidities, depression, and biochemistry data were collected at baseline. Sleep disorders including insomnia, restless legs syndrome, sleep apnea syndrome, excessive daytime sleepiness, possible narcolepsy, sleep walking and nightmares, and possible rapid eye movement behavior disorders were assessed using a panel of specific sleep questionnaires at baseline and in a second survey. Global cognitive function was measured at baseline and in a second survey, using the Modified Mini-Mental State Examination. Specific cognitive domains were evaluated using Trail-Making Test Forms A and B for executive function, and subtests of the Battery for the Assessment of Neuropsychological Status were used to asses immediate and delayed memory, visuospatial skills, and language ability. Results: Sleep disorders were common among peritoneal dialysis patients. The prevalence of cognitive impairment evaluated by the Modified Mini-Mental State Examination (3MS) increased from 19.8 to 23.9%. Possible narcolepsy was associated with decreased Modified Mini-Mental State Examination scores at baseline. During follow-up, sleepwalking and nightmares were associated with higher risks of declined delayed memory in the longitudinal study. Conclusions: Possible narcolepsy was associated with general cognitive dysfunction, and sleep walking and nightmares were risk factors for impaired delayed memory.

scholarly journals Kihito, a Traditional Japanese Kampo Medicine, Improves Cognitive Function in Alzheimer’s Disease Patients

2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Hidetoshi Watari ◽  
Yutaka Shimada ◽  
Mie Matsui ◽  
Chihiro Tohda
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Clinical Trial ◽  
Cognitive Function ◽  
Mental State ◽  
Mini Mental State Examination ◽  
Mmse Score ◽  
Photon Emission ◽  
Emission Computed Tomography ◽  
State Examination

Background and Aims. We previously reported that the administration of traditional Japanese medicines, kihito (Gui-Pi-Tang in Chinese) and kamikihito (Jia-Wei-Gui-Pi-Tang in Chinese), to Alzheimer’s disease (AD) model mice improved memory impairment. There are a few reports that show kihito and kamikihito have a beneficial effect on the cognitive function of AD patients in clinical studies. However, these studies are not comparative and are retrospective studies; thus, more evidence is needed. Therefore, we conducted an open-label, crossover designed clinical trial to investigate the effect of kihito on cognitive function of AD patients. Methods. The inclusion criteria for eligible patients were as follows: (1) imaging diagnosis (magnetic resonance imaging and single-photon emission computed tomography) of AD, (2) a treatment regimen including acetylcholinesterase inhibitors (ChEIs), and (3) a Mini-Mental State Examination (MMSE) score ≥15. The exclusion criteria were as follows: (1) change in ChEI dosage, (2) memantine usage, and (3) MMSE score < 15. To prevent bias in age and baseline cognitive function, patients were divided into two groups: the first group received 2.5 g of kihito extract 3 times/day during the first half of the study (weeks 0-16) and the second group received the same dose of kihito during the second half of the study (weeks 17-32). ChEI dosage did not change during the study period. Patients underwent a cognitive function test during weeks 0, 16, and 32. Cognitive function was evaluated by Japanese versions of the Mini-Mental State Examination (MMSE-J) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS-J) test. Results. Ten patients completed the clinical trial (4 males, 6 females, average age 71.7 years). MMSE-J scores significantly increased during the kihito intake period. RBANS-J test scores had a slight improvement during the kihito intake period compared with the ChEI alone treatment period, but no significant changes were observed. Conclusion. Kihito improves cognitive function in AD patients.

Mini-Mental State Examination and Brain Age Quotient—Short Form: Relationship and Demographic Correlates

1989 ◽  
Vol 69 (3_suppl) ◽  
pp. 1177-1178 ◽  
Author(s):  
Arthur MacNeill Horton ◽  
Stephanie Heller ◽  
Juhan Anilan ◽  
Antonio E. Puente
Keyword(s):  
Behavioral Intervention ◽  
Mental State ◽  
Mini Mental State Examination ◽  
Short Form ◽  
Demographic Correlates ◽  
Medical Program ◽  
Two Measures ◽  
State Examination ◽  
Brain Age ◽  
The Brain

Modest intercorrelations between scores on the Mini-Mental State Examination and the Brain Age Quotient were obtained for 30 men in a VA medical program for alcoholic dependency. rs with age and education were small. As the two measures are reasonably different, they may be applied to advantage in studies of behavioral intervention.

scholarly journals Mini-Mental State Examination is superior to plasma glucose concentrations in monitoring patients with suspected hypoglycaemic disorders during the 72-hour fast

2005 ◽  
Vol 152 (4) ◽  
pp. 605-610 ◽  
Author(s):  
Peter Wiesli ◽  
Beat Schwegler ◽  
Beat Schmid ◽  
Giatgen A Spinas ◽  
Christoph Schmid
Keyword(s):  
Cognitive Function ◽  
Mental State ◽  
Plasma Glucose ◽  
Glucose Concentration ◽  
Mini Mental State Examination ◽  
Mmse Score ◽  
Plasma Glucose Concentration ◽  
Systematic Evaluation ◽  
Cognitive State ◽  
State Examination

Objective: To determine whether systematic evaluation of cognitive function by the Mini-Mental State Examination (MMSE) allows the objective detection and documentation of cognitive deterioration in patients referred for evaluation of suspected hypoglycaemic disorders by the 72-h fast. Design: Prospective case series. Methods: In 50 patients referred for evaluation of suspected hypoglycaemic disorders, the MMSE score (maximum 30 points) was assessed at the start and at the end of the fast. Results: The fast was terminated before 72 h in 14 patients because they developed neuroglycopenic symptoms due to hypoglycaemic disorders. Their MMSE score fell from a median of 29 points (range 20–30) at the beginning to 17 points (range 0–24) at the termination of the fast. The score dropped by ≥6 points in all patients with hypoglycaemic disorders. Median (range) plasma glucose concentration at the end of the fast was 2.1 (1.1–2.5) mmol/l. Thirty-six individuals developed no neuroglycopenic symptoms throughout the 72-h fast, their MMSE score remained between 27 and 30 throughout the fast and their median plasma glucose concentration dropped to 2.9 (2–3.6) mmol/l. Conclusions: Systematic evaluation of cognitive function by the MMSE at the beginning and at the termination of the fast allows objective determination and documentation of the deterioration of the cognitive state in patients with hypoglycaemic disorders. A decline in the cognitive performance by ≥6 points in the MMSE score rather than a distinct plasma glucose concentration should be used as the criterion to terminate the prolonged fast before 72 h.

Sign in / Sign up

Export Citation Format

Share Document